Article
Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia.
Endocrinology - 1 Oct 2007
Nichols T C, Busby W H, Merricks E, Sipos J, Rowland M, Sitko K, Clemmons D R
Abstract excerpt
IGF-I has been shown to play a role in the progression of atherosclerosis in experimental animal models. IGF-binding protein-4 (IGFBP-4) binds to IGF-I and prevents its association with receptors. Overexpression of a protease-resistant form of IGFBP-4 has been shown to inhibit the ability of IGF-I to stimulate normal smooth muscle cell growth in mice. Based on these observations, we prepared a protease-resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
